Skip to main content
Top
Published in: Inflammopharmacology 4/2020

01-08-2020 | Naloxone | Original Article

Mechanisms involved in the antinociceptive and anti-inflammatory effects of a new triazole derivative: 5-[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole (LQFM-096)

Authors: Carina S. Cardoso, Daiany P. B. Silva, Dayane M. Silva, Iziara F. Florentino, James O. Fajemiroye, Lorrane K. S. Moreira, José P. Vasconcelos, Germán Sanz, Boniek G. Vaz, Luciano M. Lião, Danilo da S. Lima, Fernanda Cristina A. dos Santos, Ricardo Menegatti, Elson A. Costa

Published in: Inflammopharmacology | Issue 4/2020

Login to get access

Abstract

The aim of this study was to design, synthesize and evaluate the potential analgesic and anti-inflammatory effects of 5-[1-(4-fluorphenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole—(LQFM-096: a new triazole compound) as well as to elucidate its possible mechanisms of action. The oral administration of LQFM-096 (10, 20 or 40 mg/kg) decreased the number of writhing in mice. At the dose of 20 mg/kg, LQFM-096 reduced the licking time at both neurogenic and inflammatory phases of the formalin test. Pretreatment with naloxone (3 mg/kg) and glibenclamide (3 mg/kg) attenuated the antinociceptive effect of LQFM-096 in the first phase of the formalin test. At the dose of 20 mg/kg, LQFM-096 also decreased the licking time in the acidified saline-induced and capsaicin-induced nociception. This effect was blocked by naloxone (3 mg/kg) pretreatment prior to the administration of LQFM-096. In addition, LQFM-096 inhibited hyperalgesia induced by carrageenan and PGE2. Naloxone (3 mg/kg) attenuated the effect of LQFM-096 through disinhibition of PGE2-induced hyperalgesia. The anti-inflammatory effect of LQFM-096 was demonstrated in carrageenan-induced oedema or pleurisy as well as CFA-induced arthritis. The hyperalgesia and cellular migration in CFA-induced arthritis were reduced significantly. Altogether, these findings suggest antinociceptive effect of LQFM-096 and implicate the modulation of ASICs/TRPV1 channels by opioid/KATP pathway. The anti-inflammatory effect of LQFM-096 was mediated by a reduction in oedema, leukocytes migration, TNF-α, PGE2 levels and myeloperoxidase activity.
Appendix
Available only for authorised users
Literature
go back to reference Baggio CH, Freitas CS, Marcon R, Werner MF, Rae GA et al (2012) Antinociception of b-d-glucan from Pleurotus pulmuonarius is possible related to protein kinaseinhibition. Int Biol Macromol 50:872–877CrossRef Baggio CH, Freitas CS, Marcon R, Werner MF, Rae GA et al (2012) Antinociception of b-d-glucan from Pleurotus pulmuonarius is possible related to protein kinaseinhibition. Int Biol Macromol 50:872–877CrossRef
go back to reference Barbosa FL, Mori LS, Riva D, Stefanello MÉ, Zampronio AR (2013) Antinociceptive and anti-inflammatory activities of the ethanolic extract, fractions and 8-methoxylapachenol from Sinningia allagophylla tubers. Basic Clin Pharmacol Toxicol 113:1–7CrossRef Barbosa FL, Mori LS, Riva D, Stefanello MÉ, Zampronio AR (2013) Antinociceptive and anti-inflammatory activities of the ethanolic extract, fractions and 8-methoxylapachenol from Sinningia allagophylla tubers. Basic Clin Pharmacol Toxicol 113:1–7CrossRef
go back to reference Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R et al (2008) Opioid complications and side effects. Pain Physician 11:S105–S120PubMed Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R et al (2008) Opioid complications and side effects. Pain Physician 11:S105–S120PubMed
go back to reference Campbell VC, Welch SP (2001) The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids. Eur J Pharmacol 417(1–2):91–98CrossRef Campbell VC, Welch SP (2001) The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids. Eur J Pharmacol 417(1–2):91–98CrossRef
go back to reference Chandy RL, Moore PK (1998) Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology 37(1):37–43CrossRef Chandy RL, Moore PK (1998) Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology 37(1):37–43CrossRef
go back to reference Chopade AR, Sayyad FJ (2013) Antinociceptive effect of Phyllanthus fraternus extract in complete Freund’s adjuvant induced chronic pain in mice. Biomed Aging Pathol 3:235–240CrossRef Chopade AR, Sayyad FJ (2013) Antinociceptive effect of Phyllanthus fraternus extract in complete Freund’s adjuvant induced chronic pain in mice. Biomed Aging Pathol 3:235–240CrossRef
go back to reference Dheer D, Singh V, Shankar R (2017) Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 71:30–54CrossRef Dheer D, Singh V, Shankar R (2017) Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 71:30–54CrossRef
go back to reference Di Rosa M (1972) Biological properties of carrageenan. J Pharmacol 24(2):89–102CrossRef Di Rosa M (1972) Biological properties of carrageenan. J Pharmacol 24(2):89–102CrossRef
go back to reference Giorno TBS, Da Silva BV, Pinto AC, Fernandes PD (2016) Antinociceptive effect and mechanismof action of isatin, N-methyl isatin and oxopropyl isatin in mice. Life Sci 15:189–198CrossRef Giorno TBS, Da Silva BV, Pinto AC, Fernandes PD (2016) Antinociceptive effect and mechanismof action of isatin, N-methyl isatin and oxopropyl isatin in mice. Life Sci 15:189–198CrossRef
go back to reference Gregory N, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA (2013) An overview of animal models of pain: disease models and outcome measures. J Pain 14(11):1255–1269CrossRef Gregory N, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA (2013) An overview of animal models of pain: disease models and outcome measures. J Pain 14(11):1255–1269CrossRef
go back to reference Haegens A, Heeringa P, Suylen RJV, Steele C, Aratani Y et al (2009) Myeloperoxidase deficiency attenuates Lipopolysaccharide-induced acute lung inflammation and subsequent citokyne and chemokine production. J Immunol 182(12):7990–7996CrossRef Haegens A, Heeringa P, Suylen RJV, Steele C, Aratani Y et al (2009) Myeloperoxidase deficiency attenuates Lipopolysaccharide-induced acute lung inflammation and subsequent citokyne and chemokine production. J Immunol 182(12):7990–7996CrossRef
go back to reference http://www.iasp-pain.org/Taxonomy. Pain terms, a current list with definitions and notes on usage (pp 209–214). Classification of Chronic Pain, Second Edition, IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk, IASP Press, Seattle, ©1994 http://​www.​iasp-pain.​org/​Taxonomy. Pain terms, a current list with definitions and notes on usage (pp 209–214). Classification of Chronic Pain, Second Edition, IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk, IASP Press, Seattle, ©1994
go back to reference Joanna L, Talarek S, Orzelska J, Fidecka S, Wujec M, Plech T (2014) The antinociceptive effect of 4-substituted derivatives of 5-(4-chlorophenyl)-2-(morpholin-4-ylmethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in mice. Naunyn-Schmiedeberg’s Arch Pharmacol 387:367–375. https://doi.org/10.1007/s00210-013-0938-0 CrossRef Joanna L, Talarek S, Orzelska J, Fidecka S, Wujec M, Plech T (2014) The antinociceptive effect of 4-substituted derivatives of 5-(4-chlorophenyl)-2-(morpholin-4-ylmethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in mice. Naunyn-Schmiedeberg’s Arch Pharmacol 387:367–375. https://​doi.​org/​10.​1007/​s00210-013-0938-0 CrossRef
go back to reference Kawabata A (2001) Prostaglandin E2 and pain—an update. Biol Pharm Bull 34(8):1170–1173CrossRef Kawabata A (2001) Prostaglandin E2 and pain—an update. Biol Pharm Bull 34(8):1170–1173CrossRef
go back to reference Klebanoff SJ (2005) Myeloperoxidase: a friend and foe. J Leuk Biol 77:598–625CrossRef Klebanoff SJ (2005) Myeloperoxidase: a friend and foe. J Leuk Biol 77:598–625CrossRef
go back to reference Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412 Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412
go back to reference L’abbé G, Bruynseels M, Delbeke P, Topper S (1990) Molecular rearrangements of 4-iminomethyl-1,2,3-triazoles replacement of 1-aryl substituents in 1H-1,2,3-triazoles-4-carbaldehydes. J Heterocycl Chem 27:2021CrossRef L’abbé G, Bruynseels M, Delbeke P, Topper S (1990) Molecular rearrangements of 4-iminomethyl-1,2,3-triazoles replacement of 1-aryl substituents in 1H-1,2,3-triazoles-4-carbaldehydes. J Heterocycl Chem 27:2021CrossRef
go back to reference Lima LM, Barreiro EJ (2005) Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 12:23–49CrossRef Lima LM, Barreiro EJ (2005) Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 12:23–49CrossRef
go back to reference Ma W, Quirion R (2007) Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 11(3):307–320CrossRef Ma W, Quirion R (2007) Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 11(3):307–320CrossRef
go back to reference Moore AR (2003) Pleural models of inflammation: immune and noimmune. In: Winyard PG, Willoughby DA (eds) Inflammation protocols. Humana Press, Totowa, pp 123–128CrossRef Moore AR (2003) Pleural models of inflammation: immune and noimmune. In: Winyard PG, Willoughby DA (eds) Inflammation protocols. Humana Press, Totowa, pp 123–128CrossRef
go back to reference Passos GF, Fernandes ES, da Cunha FM, Ferreira J, Pianowski LF et al (2007) Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J Ethnopharmacol 110(2):323–333CrossRef Passos GF, Fernandes ES, da Cunha FM, Ferreira J, Pianowski LF et al (2007) Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J Ethnopharmacol 110(2):323–333CrossRef
go back to reference Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Thér 4:409–419 Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Thér 4:409–419
go back to reference Sakurada T, Katsumata K, Tan-No K, Sakurada S, Kisara K (1992) The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacol J 31:1279–1285CrossRef Sakurada T, Katsumata K, Tan-No K, Sakurada S, Kisara K (1992) The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacol J 31:1279–1285CrossRef
go back to reference Saleh TSF, Calixto JB, Medeiros YS (1999) Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 20(8):949–956CrossRef Saleh TSF, Calixto JB, Medeiros YS (1999) Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 20(8):949–956CrossRef
go back to reference Sedgwick AD (1995) Initiation of inflammatory response and its prevention. In: Bonta IL, Bray MA (eds) EUA: handbook of inflammation. Elsevier, New York, p 253 Sedgwick AD (1995) Initiation of inflammatory response and its prevention. In: Bonta IL, Bray MA (eds) EUA: handbook of inflammation. Elsevier, New York, p 253
go back to reference Sehgal N, Smith H, Manchikanti L (2011) Peripherally acting opioids and clinical implications for pain control. Pain Physician 14:249–258PubMed Sehgal N, Smith H, Manchikanti L (2011) Peripherally acting opioids and clinical implications for pain control. Pain Physician 14:249–258PubMed
go back to reference Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic biphasic pain response. Pain 38(3):347–352CrossRef Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic biphasic pain response. Pain 38(3):347–352CrossRef
go back to reference Sokal RR, Rohlf FJ (1981) Biometry: the principles and practice of statistics in biological research. W.H. Freeman and Co., New York Sokal RR, Rohlf FJ (1981) Biometry: the principles and practice of statistics in biological research. W.H. Freeman and Co., New York
go back to reference Trost BM (1991) The atom economy–a search for synthetic efficiency. Science 254:1471CrossRef Trost BM (1991) The atom economy–a search for synthetic efficiency. Science 254:1471CrossRef
go back to reference Watanabe M, Ueda T, Shibata Y, Kumamoto N, Ugawa S (2015) The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice. NeuroReport 26(3):173–178CrossRef Watanabe M, Ueda T, Shibata Y, Kumamoto N, Ugawa S (2015) The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice. NeuroReport 26(3):173–178CrossRef
go back to reference White JPM, Cibelli M, Fidalgo AR (2010) Role of transient receptor potential and acid-sensing ion channels in peripheral inflammatory pain. Anesthesiology 112:729–741CrossRef White JPM, Cibelli M, Fidalgo AR (2010) Role of transient receptor potential and acid-sensing ion channels in peripheral inflammatory pain. Anesthesiology 112:729–741CrossRef
go back to reference Yet L (2018) Privileged structures in drug discovery medicinal chemistry and synthesis, 1st edn. Wiley, Hoboken Yet L (2018) Privileged structures in drug discovery medicinal chemistry and synthesis, 1st edn. Wiley, Hoboken
Metadata
Title
Mechanisms involved in the antinociceptive and anti-inflammatory effects of a new triazole derivative: 5-[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole (LQFM-096)
Authors
Carina S. Cardoso
Daiany P. B. Silva
Dayane M. Silva
Iziara F. Florentino
James O. Fajemiroye
Lorrane K. S. Moreira
José P. Vasconcelos
Germán Sanz
Boniek G. Vaz
Luciano M. Lião
Danilo da S. Lima
Fernanda Cristina A. dos Santos
Ricardo Menegatti
Elson A. Costa
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 4/2020
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-020-00685-8

Other articles of this Issue 4/2020

Inflammopharmacology 4/2020 Go to the issue